The cellular and humoral immune response to influenza vaccination is comparable in asthmatic and healthy subjects

References

• Wright PF, Webster R. Orthomyxoviruses. In: Virology Knipe DM, Howley PM editors. Fields. 4th. Philadelphia (PA): Lippincott Williams & Wilkins; 2001. p. 1534–79.
   Google Scholar
• Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices—United States, 2013-2014. MMWR Morb Mortal Wkly Rep 2013;62:1–43.
   PubMed Web of Science ®Google Scholar
• Kondo S, Abe K. The effects of influenza virus infection on FEV1 in asthmatic children. The time-course study. Chest. 1991;100(5):1235–38. doi:10.1378/chest.100.5.1235.
   PubMed Web of Science ®Google Scholar
• Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000;283(4):499–505. doi:10.1001/jama.283.4.499.
   PubMed Web of Science ®Google Scholar
• Worl Health Organization. Vaccines against influenza WHO position paper-November 2012. Wkly Epidemiol Rec 2012;87::461–76.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Prac- tices (ACIP), United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep. 2012;61::613–18. doi:10.1016/s0002-9378(16)33297-5.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Immunization Practices Advisory Committee. Prevention and control of influenza: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 2002;51:1–31.
   Google Scholar
• Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, Kemble G, Connor EM. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med. 2007;356(7):685–96. doi:10.1056/NEJMoa065368.
   PubMed Web of Science ®Google Scholar
• Cates CJ, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev. 2013;(2)CD000364. doi:10.1002/14651858.CD000364.pub4.
   PubMed Web of Science ®Google Scholar
• Hanania NA, Sockrider M, Castro M, Holbrook JT, Tonascia J, Wise R, Atmar RL. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol. 2004;113(4):717–24. doi:10.1016/j.jaci.2003.12.584.
   PubMed Web of Science ®Google Scholar
• Fairchok MP, Trementozzi DP, Carter PS, Regnery HL, Carter ER. Effect of prednisone on response to influenza virus vaccine in asthmatic children. Arch Pediatr Adolesc Med. 1998;152(12):1191–95. doi:10.1001/archpedi.152.12.1191.
   PubMedGoogle Scholar
• Hilleman MR. Vaccines in historic evolution and perspective: a narrative of vaccine discoveries. Vaccine. 2000;18(15):1436–47. doi:10.1016/S0264-410X(99)00434-X.
   PubMed Web of Science ®Google Scholar
• Butcher EC, Williams M, Youngman K, Rott L, Briskin M. Lymphocyte trafficking and regional immunity. Adv Immunol. 1999;72:209–53. doi:10.1016/s0065-2776(08)60022-x.
   PubMed Web of Science ®Google Scholar
• Campbell JJ, Butcher EC. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol. 2000;12(3):336–41. doi:10.1016/s0952-7915(00)00096-0.
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401(6754):708–12. doi:10.1038/44385.
   PubMed Web of Science ®Google Scholar
• Plotkin SA, Orenstein WA, Offit PA. Vaccines. Scotland: Elsevier; 2013.
   Google Scholar
• Kuruvilla ME, Lee FE, Lee GB, Phenotypes UA. Endotypes, and mechanisms of disease. Clin Rev Allergy Immunol. 2019;56(2):219–33. doi:10.1007/s12016-018-8712-1.
   PubMed Web of Science ®Google Scholar
• Veerapandian R, Snyder JD, Samarasinghe AE. Influenza in asthmatics: for better or for worse? Front Immunol. 2018;9:1843. doi:10.3389/fimmu.2018.01843.
   PubMed Web of Science ®Google Scholar
• Vasileiou E, Sheikh A, Butler C, El Ferkh K, von Wissmann B, McMenamin J, Ritchie L, Schwarze J, Papadopoulos NG, Johnston SL, et al. Effectiveness of influenza vaccines in asthma: a systematic review and meta-analysis. Clin Infect Dis. 2017;65(8):1388–95. doi:10.1093/cid/cix524.
   PubMed Web of Science ®Google Scholar
• Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices-United States, 2018-19 influenza season. MMWR Recommendations Rep. 2018;67(3):1–20. doi:10.15585/mmwr.rr6703a1.
   PubMed Web of Science ®Google Scholar
• Schwarze J, Openshaw P, Jha A, Del Giacco SR, Firinu D, Tsilochristou O, Roberts G, Selby A, Akdis C, Agache I, et al. Influenza burden, prevention, and treatment in asthma-A scoping review by the EAACI Influenza in asthma task force. Allergy. 2018;73(6):1151–81. doi:10.1111/all.13333.
   PubMed Web of Science ®Google Scholar
• Kumar A, McElhaney JE, Walrond L, Cyr TD, Merani S, Kollmann TR, Halperin SA, Scheifele DW. Cellular immune responses of older adults to four influenza vaccines: results of a randomized, controlled comparison. Hum Vaccin Immunother. 2017;13(9):2048–57. doi:10.1080/21645515.2017.1337615.
   PubMed Web of Science ®Google Scholar
• Bohm L, Maxeiner J, Meyer-Martin H, Reuter S, Finotto S, Klein M, Schild H, Schmitt E, Bopp T, Taube C, et al. IL-10 and regulatory T cells cooperate in allergen-specific immunotherapy to ameliorate allergic asthma. J Immunol. 2015;194(3):887–97. doi:10.4049/jimmunol.1401612.
   PubMed Web of Science ®Google Scholar
• Morbidity and Mortality Weekly Report. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices, United States. MMWR Recommendations Rep. 2019;68(3):1–21.
   Web of Science ®Google Scholar
• Nayak JL, Fitzgerald TF, Richards KA, Yang H, Treanor JJ, Sant AJ. CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine. J Infect Dis. 2013;207(2):297–305. doi:10.1093/infdis/jis684.
   PubMed Web of Science ®Google Scholar
• van de Sandt CE, Hillaire ML, Geelhoed-Mieras MM, Osterhaus AD, Fouchier RA, Rimmelzwaan GF. Human influenza A virus–specific CD8+ T-cell response is long-lived. J Infect Dis. 2015;212(1):81–85. doi:10.1093/infdis/jiv018.
   PubMed Web of Science ®Google Scholar
• Grant EJ, Quinones-Parra SM, Clemens EB, Kedzierska K. Human influenza viruses and CD8(+) T cell responses. Curr Opin Virol. 2016;16:132–42. doi:10.1016/j.coviro.2016.01.016.
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, Ewen C, Kane KP, Bleackley RC. T cell responses are better correlates of vaccine protection in the elderly. J Immunol. 2006;176(10):6333–39. doi:10.4049/jimmunol.176.10.6333.
   PubMed Web of Science ®Google Scholar
• Giuffrida MJ, Valero N, Mosquera J, Alvarez de Mon M, Chacin B, Espina LM, Gotera J, Bermudez J, Mavarez A. Increased cytokine/chemokines in serum from asthmatic and non-asthmatic patients with viral respiratory infection. Influenza Other Respir Viruses. 2014;8(1):116–22. doi:10.1111/irv.12155.
   PubMed Web of Science ®Google Scholar